The Millennium Materials Technologies (MMT) funds were created to invest in the development and commercialization of novel advanced
The Millennium Materials Technologies (MMT) funds were created to invest in the development and commercialization of novel advanced materials used in high growth industries like micro-electronics, pharmaceuticals, biotechnology, agro/chemicals, polymers and communication materials.Founded in 1998, the MMT funds are among the few exclusive funds dedicated to the unique focus of material science - an area experiencing exponential growth while fueling industrial and technology advancements in the 21st century.The MMT Funds are focused on investing in companies developing advanced materials in the fields of nano-technology, polymer technologies, bio-materials, energy & environmental technologies, industrial chemistry and novel crystals, with a special focus on Israeli and Israeli related (60-70%) companies.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Feb 2, 2009
Enzymotec
|
Series B | $11M | Biotechnology | — |
Nov 16, 2005
Mempile
|
Series C | $10.50M | Digital Entertainment | — |
Jan 1, 2005
Glycominds
|
Series Unknown | $1M | Biotechnology | — |
Dec 1, 2004
Cymbet
|
Series B | $16.50M | Energy Storage | — |
Mar 3, 2004
Mempile
|
Series B | $11.60M | Digital Entertainment | — |